JP2000504742A - コントラスト媒体 - Google Patents
コントラスト媒体Info
- Publication number
- JP2000504742A JP2000504742A JP9529894A JP52989497A JP2000504742A JP 2000504742 A JP2000504742 A JP 2000504742A JP 9529894 A JP9529894 A JP 9529894A JP 52989497 A JP52989497 A JP 52989497A JP 2000504742 A JP2000504742 A JP 2000504742A
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- agent
- viscosity
- viscosity modifier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002872 contrast media Substances 0.000 title claims abstract description 56
- 239000004034 viscosity adjusting agent Substances 0.000 claims abstract description 37
- 210000003750 lower gastrointestinal tract Anatomy 0.000 claims abstract description 9
- 239000002357 osmotic agent Substances 0.000 claims abstract description 8
- 239000000203 mixture Substances 0.000 claims description 115
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical group [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 52
- 210000001072 colon Anatomy 0.000 claims description 37
- 238000003384 imaging method Methods 0.000 claims description 35
- 230000003204 osmotic effect Effects 0.000 claims description 28
- 239000003795 chemical substances by application Substances 0.000 claims description 26
- 238000000576 coating method Methods 0.000 claims description 15
- 239000011248 coating agent Substances 0.000 claims description 14
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 150000004676 glycans Chemical class 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 230000000112 colonic effect Effects 0.000 claims description 10
- 239000003607 modifier Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 229920003086 cellulose ether Polymers 0.000 claims description 8
- 239000006185 dispersion Substances 0.000 claims description 7
- 229920001515 polyalkylene glycol Polymers 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 6
- 229920000233 poly(alkylene oxides) Polymers 0.000 claims description 6
- 244000043261 Hevea brasiliensis Species 0.000 claims description 5
- 210000004877 mucosa Anatomy 0.000 claims description 5
- 229920003052 natural elastomer Polymers 0.000 claims description 5
- 229920001194 natural rubber Polymers 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- 239000013011 aqueous formulation Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 238000002405 diagnostic procedure Methods 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims description 3
- 229910052740 iodine Inorganic materials 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 230000003232 mucoadhesive effect Effects 0.000 claims description 3
- 150000005846 sugar alcohols Polymers 0.000 claims description 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 2
- 229940072056 alginate Drugs 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229920001400 block copolymer Polymers 0.000 claims description 2
- 230000006872 improvement Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 claims description 2
- 210000002438 upper gastrointestinal tract Anatomy 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 6
- 239000007900 aqueous suspension Substances 0.000 claims 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 238000009472 formulation Methods 0.000 description 43
- 241000282472 Canis lupus familiaris Species 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 description 12
- 229920001223 polyethylene glycol Polymers 0.000 description 12
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 10
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 9
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 9
- 239000003086 colorant Substances 0.000 description 8
- 229940039231 contrast media Drugs 0.000 description 8
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 7
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 7
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 7
- 239000008108 microcrystalline cellulose Substances 0.000 description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 7
- 239000004302 potassium sorbate Substances 0.000 description 7
- 235000010241 potassium sorbate Nutrition 0.000 description 7
- 229940069338 potassium sorbate Drugs 0.000 description 7
- 229940085605 saccharin sodium Drugs 0.000 description 7
- 229940083037 simethicone Drugs 0.000 description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 7
- 235000010234 sodium benzoate Nutrition 0.000 description 7
- 239000004299 sodium benzoate Substances 0.000 description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 7
- 229920003091 Methocel™ Polymers 0.000 description 6
- -1 US-A-5330739 Chemical class 0.000 description 6
- 230000001174 ascending effect Effects 0.000 description 6
- 229910052788 barium Inorganic materials 0.000 description 6
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000002594 fluoroscopy Methods 0.000 description 5
- 229940031705 hydroxypropyl methylcellulose 2910 Drugs 0.000 description 5
- WQNHWIYLCRZRLR-UHFFFAOYSA-N 2-(3-hydroxy-2,5-dioxooxolan-3-yl)acetic acid Chemical compound OC(=O)CC1(O)CC(=O)OC1=O WQNHWIYLCRZRLR-UHFFFAOYSA-N 0.000 description 4
- 241000207199 Citrus Species 0.000 description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 229940051147 fd&c yellow no. 6 Drugs 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 4
- 230000005291 magnetic effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002359 Tetronic® Polymers 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 235000010980 cellulose Nutrition 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 210000001731 descending colon Anatomy 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 210000004051 gastric juice Anatomy 0.000 description 3
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 3
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 3
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 210000003384 transverse colon Anatomy 0.000 description 3
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- 241000792859 Enema Species 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003094 Methocel™ K4M Polymers 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000001815 ascending colon Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 238000011833 dog model Methods 0.000 description 2
- 239000007920 enema Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- SQORATIMOBOFKR-UHFFFAOYSA-H gadolinium(3+);oxalate Chemical compound [Gd+3].[Gd+3].[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O.[O-]C(=O)C([O-])=O SQORATIMOBOFKR-UHFFFAOYSA-H 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000010954 inorganic particle Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000006249 magnetic particle Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 238000011176 pooling Methods 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- ZEYOIOAKZLALAP-UHFFFAOYSA-M sodium amidotrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I ZEYOIOAKZLALAP-UHFFFAOYSA-M 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002609 virtual colonoscopy Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- GQWNECFJGBQMBO-UHFFFAOYSA-N Molindone hydrochloride Chemical class Cl.O=C1C=2C(CC)=C(C)NC=2CCC1CN1CCOCC1 GQWNECFJGBQMBO-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 229920002534 Polyethylene Glycol 1450 Polymers 0.000 description 1
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 206010056626 Pseudopolyp Diseases 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000004697 chelate complex Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013170 computed tomography imaging Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002961 echo contrast media Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 229940095399 enema Drugs 0.000 description 1
- 229940079360 enema for constipation Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 230000005294 ferromagnetic effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 230000026045 iodination Effects 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 239000002907 paramagnetic material Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920001987 poloxamine Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 208000022131 polyp of large intestine Diseases 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0404—X-ray contrast preparations containing barium sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1806—Suspensions, emulsions, colloids, dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/226—Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Acoustics & Sound (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9603547.2 | 1996-02-20 | ||
| GBGB9603547.2A GB9603547D0 (en) | 1996-02-20 | 1996-02-20 | Contrast media |
| PCT/GB1997/000473 WO1997030736A2 (fr) | 1996-02-20 | 1997-02-20 | Milieu de contraste |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000504742A true JP2000504742A (ja) | 2000-04-18 |
Family
ID=10789076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9529894A Pending JP2000504742A (ja) | 1996-02-20 | 1997-02-20 | コントラスト媒体 |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0881916A2 (fr) |
| JP (1) | JP2000504742A (fr) |
| KR (1) | KR19990087196A (fr) |
| CN (1) | CN1215342A (fr) |
| AU (1) | AU1885297A (fr) |
| BR (1) | BR9710946A (fr) |
| CA (1) | CA2247041A1 (fr) |
| GB (1) | GB9603547D0 (fr) |
| HU (1) | HUP9901323A2 (fr) |
| NO (1) | NO983828L (fr) |
| WO (1) | WO1997030736A2 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016528259A (ja) * | 2013-08-16 | 2016-09-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | シリコーン系腸管ｃｔ造影材料 |
| JP2018507165A (ja) * | 2015-09-30 | 2018-03-15 | デューク・ユニヴァーシティ | アスコルベート製剤及び造影剤としての使用方法 |
| US11033640B2 (en) | 2013-03-15 | 2021-06-15 | The Regents Of The University Of California | Enteric CT contrast material based on low-z atoms |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6928314B1 (en) | 1998-01-23 | 2005-08-09 | Mayo Foundation For Medical Education And Research | System for two-dimensional and three-dimensional imaging of tubular structures in the human body |
| DE19844495B4 (de) * | 1998-09-29 | 2005-04-07 | Man Roland Druckmaschinen Ag | Verfahren zur Farbkalibrierung mittels Colormanagement für eine digital ansteuerbare Druckmaschine mit einer wiederbeschreibbaren Druckform |
| JP3461750B2 (ja) | 1999-03-04 | 2003-10-27 | パナソニック コミュニケーションズ株式会社 | 通信装置、通信方法、および発信者情報の登録方法 |
| AUPQ605500A0 (en) | 2000-03-07 | 2000-03-30 | Medefield Pty Ltd | Stool marker |
| US7591998B2 (en) | 2000-03-07 | 2009-09-22 | Kevin Tait | Stool marker |
| US6477401B1 (en) | 2000-03-10 | 2002-11-05 | Mayo Foundation For Medical Education And Research | Colonography of an unprepared colon |
| WO2007030132A2 (fr) | 2005-02-14 | 2007-03-15 | Mayo Foundation For Medical Education And Research | Soustraction electronique des matieres fecales en colographie par tomographie par ordinateur |
| US8043604B2 (en) * | 2007-04-27 | 2011-10-25 | Pluromed, Inc. | Ultrasonography using time- and temperature-sensitive variable adhesion coupling gels |
| CN104587494A (zh) * | 2014-12-19 | 2015-05-06 | 张锐 | 一种胃肠钡餐造影配方及其制备方法 |
| CN106075476B (zh) * | 2016-07-30 | 2019-05-31 | 温州市人民医院 | 一种造影剂 |
| US20210186819A1 (en) * | 2018-09-07 | 2021-06-24 | Moore Dental Technologies And Solutions Llc | Dental Fracture Detection Compositions and Methods |
| CN109540936A (zh) * | 2019-01-11 | 2019-03-29 | 大连大学附属中山医院 | 一种用于高分辨率ct及x线动脉、静脉或管道的室温造影剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55501057A (fr) * | 1978-12-19 | 1980-12-04 | ||
| GB8916782D0 (en) * | 1989-07-21 | 1989-09-06 | Nycomed As | Compositions |
| AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
| US5352459A (en) * | 1992-12-16 | 1994-10-04 | Sterling Winthrop Inc. | Use of purified surface modifiers to prevent particle aggregation during sterilization |
| WO1995022995A1 (fr) * | 1994-02-25 | 1995-08-31 | Nycomed Imaging A/S | Compositions de contraste radiologique contenant des derives de la cellulose |
-
1996
- 1996-02-20 GB GBGB9603547.2A patent/GB9603547D0/en active Pending
-
1997
- 1997-02-20 JP JP9529894A patent/JP2000504742A/ja active Pending
- 1997-02-20 CA CA002247041A patent/CA2247041A1/fr not_active Abandoned
- 1997-02-20 BR BR9710946-0A patent/BR9710946A/pt not_active Application Discontinuation
- 1997-02-20 KR KR1019980706591A patent/KR19990087196A/ko not_active Application Discontinuation
- 1997-02-20 CN CN97193663A patent/CN1215342A/zh active Pending
- 1997-02-20 WO PCT/GB1997/000473 patent/WO1997030736A2/fr not_active Application Discontinuation
- 1997-02-20 HU HU9901323A patent/HUP9901323A2/hu unknown
- 1997-02-20 EP EP97905227A patent/EP0881916A2/fr not_active Withdrawn
- 1997-03-20 AU AU18852/97A patent/AU1885297A/en not_active Abandoned
-
1998
- 1998-08-20 NO NO983828A patent/NO983828L/no unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11033640B2 (en) | 2013-03-15 | 2021-06-15 | The Regents Of The University Of California | Enteric CT contrast material based on low-z atoms |
| JP2016528259A (ja) * | 2013-08-16 | 2016-09-15 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | シリコーン系腸管ｃｔ造影材料 |
| JP2019072505A (ja) * | 2013-08-16 | 2019-05-16 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | シリコーン系腸管ｃｔ造影材料 |
| JP2021193113A (ja) * | 2013-08-16 | 2021-12-23 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California | シリコーン系腸管ｃｔ造影材料 |
| JP2018507165A (ja) * | 2015-09-30 | 2018-03-15 | デューク・ユニヴァーシティ | アスコルベート製剤及び造影剤としての使用方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1215342A (zh) | 1999-04-28 |
| AU1885297A (en) | 1997-09-10 |
| NO983828L (no) | 1998-10-15 |
| EP0881916A2 (fr) | 1998-12-09 |
| NO983828D0 (no) | 1998-08-20 |
| HUP9901323A2 (hu) | 1999-08-30 |
| GB9603547D0 (en) | 1996-04-17 |
| KR19990087196A (ko) | 1999-12-15 |
| WO1997030736A3 (fr) | 1997-12-18 |
| BR9710946A (pt) | 2000-10-31 |
| CA2247041A1 (fr) | 1997-08-28 |
| WO1997030736A2 (fr) | 1997-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5593657A (en) | Barium salt formulations stabilized by non-ionic and anionic stabilizers | |
| JP2000504742A (ja) | コントラスト媒体 | |
| JP2865172B2 (ja) | 経皮のリンパ管造影 | |
| RU2124886C1 (ru) | Частицы, включающие плохо растворимое кристаллическое терапевтическое или диагностическое средство, и способ их получения | |
| JP6843787B2 (ja) | 低ｚ原子による腸管ｃｔ造影材料 | |
| JPH10502341A (ja) | 微小結晶製剤用の安定剤被膜としてのブチレンオキサイド−エチレンオキサイドブロック共重合体界面活性剤 | |
| JPH11500733A (ja) | 微小粒子のための表面改質剤としてのポリアルキレンブロックコポリマー | |
| JPH10502082A (ja) | 血液プール及びリンパ系のｘ線写真造影剤としてのジアトリゾキシエステル | |
| JPH06192131A (ja) | Ｘ線診断用組成物、その製造方法、及びそれによる診断方法 | |
| US20200179539A1 (en) | Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation | |
| EP1677677B1 (fr) | Milieu de contraste utilise dans des procedures medicales et diagnostiques et ses procedes d'utilisation | |
| JP2016528259A (ja) | シリコーン系腸管ｃｔ造影材料 | |
| US5342605A (en) | Polymeric X-ray compositions containing iodinated polymeric beads | |
| Owens et al. | CT and X-ray contrast agents: current clinical challenges and the future of contrast | |
| US5352434A (en) | X-ray contrast compositions containing a barium salt and film-forming materials | |
| JPH0625016A (ja) | 皮膜形成物質を含有するｘ線造影組成物 | |
| Sireci | Clinical utility of barium sulfate products: Formulation determines appropriate use | |
| JP2003519200A (ja) | 腸管腔の視覚化のための診断剤の製造における造影剤の使用 | |
| JPH08500604A (ja) | バリウム塩及びフィルム形成性物質を含有するｘ線コントラスト組成物 | |
| McKee et al. | Barium sulfate products for roentgenographic examination of the gastrointestinal tract | |
| JP2001525846A (ja) | 造影剤 | |
| JP5696326B2 (ja) | Ｃｔコロノグラフィ検査用医薬 | |
| US20240123093A1 (en) | Double-component gastric ultrasound examination aided developer and preparation method therefor | |
| US3590115A (en) | Radiological mixture and method of preparing the gastro-intestinal system for x-ray photography | |
| EP1138331A2 (fr) | Marqueur de selles |